Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nat Rev Nephrol ; 11(3): 183-8, 2015 03.
Artigo em Inglês | MEDLINE | ID: mdl-25511761

RESUMO

Establishing a programme for the prevention and treatment of acute kidney injury, chronic kidney disease and end-stage renal disease in a developing country involves unique challenges. We became involved in a collaborative effort to improve nephrology care in Haiti after participating in the emergency response to the 2010 earthquake. The focus of this ongoing project is overcoming barriers to implementation with the goal of improving training and resources for Haitian health-care workers and developing programmes for renal disease prevention and treatment in a setting of limited resources. Here, we offer practical advice for nephrologists who would like to help to advance medical care in developing countries. Rather than technical issues related to the prevention and treatment of renal disease, we focus on collaboration, education and the building of partnerships.


Assuntos
Países em Desenvolvimento , Nefropatias/terapia , Haiti , Acessibilidade aos Serviços de Saúde , Humanos , Nefropatias/epidemiologia , Parcerias Público-Privadas
2.
Am J Kidney Dis ; 49(3): 401-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17336701

RESUMO

BACKGROUND: Hemodialysis patients with tunneled catheters are at increased risk of bacteremic Staphylococcus aureus infections. In vitro and in vivo studies showed that aspirin has direct antistaphylococcal effects by inhibiting expression of alpha-toxin and matrix adhesion genes through activation of sigma factor B stress-induced operon. We hypothesized that long-term treatment with aspirin may decrease the frequency of S aureus bacteremia in such patients. METHODS: We retrospectively analyzed electronic medical records for a variety of clinical parameters, including catheter dwell times, blood culture results, and aspirin use in our dialysis population. RESULTS: A total of 4,722 blood cultures were performed in 872 patients during more than 476 patient-catheter-years. There was a lower rate of catheter-associated S aureus bacteremia in patients treated with aspirin versus those not treated with aspirin (0.17 versus 0.34 events/patient-catheter-year, P = 0.003), whereas no such difference was observed for other bacteria. This association was dose dependent, seen mostly with the 325-mg aspirin dose. Using the Cox proportional hazard method, risk to develop a first episode of S aureus bacteremia decreased by 54% in patients using aspirin (confidence interval, 24 to 72; P = 0.002). Aspirin was associated with decreased risk of: (1) a first episode of methicillin-resistant S aureus bacteremia and (2) metastatic complications during the first episode of catheter-related S aureus bacteremia. CONCLUSION: These data are consistent with our clinical hypothesis that aspirin has a clinically useful antistaphylococcal effect in the dialysis population.


Assuntos
Antibacterianos/uso terapêutico , Aspirina/uso terapêutico , Bacteriemia/prevenção & controle , Cateteres de Demora/efeitos adversos , Diálise Renal/efeitos adversos , Infecções Estafilocócicas/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Bacteriemia/etiologia , Cateteres de Demora/microbiologia , Feminino , Humanos , Nefropatias/terapia , Masculino , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Diálise Renal/instrumentação , Estudos Retrospectivos , Infecções Estafilocócicas/etiologia , Staphylococcus aureus/patogenicidade
4.
Semin Dial ; 19(6): 496-501, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17150050

RESUMO

The development of many electrolyte disturbances in the ICU can be prevented by attention to the use of intravenous fluids and nutrition. Hyponatremia is a relative contraindication to the use of hypotonic intravenous fluids and hypernatremia calls for the administration of water. Formulae have been devised to guide the therapy of severe hyponatremia and hypernatremia. All formulae regard the patient as a closed system, and none takes into account ongoing fluid losses that are highly variable between patients. Thus, therapy of severe hyponatremia and hypernatremia must be closely monitored with serial electrolyte measurements. The significance of hypocalcemia in the critically ill is controversial. Hypokalemia, hypophosphatemia, and hypomagnesemia should be corrected.


Assuntos
Unidades de Terapia Intensiva , Desequilíbrio Hidroeletrolítico/metabolismo , Humanos , Hiperpotassemia/metabolismo , Hipernatremia/metabolismo , Hipocalcemia/metabolismo , Hipopotassemia/metabolismo , Hiponatremia/metabolismo , Hipofosfatemia/metabolismo , Magnésio/sangue , Desequilíbrio Hidroeletrolítico/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...